Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CALL
Estee Lauder
EL
$31.6B
| $2.8M | ﹤0.01% |
+11,000
| New | +$2.79M |
|
3327
CALL
American Airlines Group
AAL
$10.2B
| $2.79M | ﹤0.01% |
220,400
+159,400
| +261% | +$2.65M |
|
|
DICE
3328
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $2.79M | ﹤0.01% |
179,620
-101,776
| -36% | -$1.75M |
|
3329
Aclaris Therapeutics
ACRS
$870M
| $2.77M | ﹤0.01% |
198,794
+142,581
| +254% | +$2M |
|
|
LUNA
3330
DELISTED
Luna Innovations Incorporated
LUNA
| $2.77M | ﹤0.01% |
475,221
+340,907
| +254% | +$2.01M |
|
3331
Edison International
EIX
$26.6B
| $2.77M | ﹤0.01% |
43,746
-60,116
| -58% | -$4.07M |
|
3332
Viemed Healthcare
VMD
$354M
| $2.77M | ﹤0.01% |
514,131
+388,790
| +310% | +$2.1M |
|
3333
iShares US Aerospace & Defense ETF
ITA
$15B
| $2.76M | ﹤0.01% |
27,870
-2,830
| -9% | -$291K |
|
3334
Middlesex Water
MSEX
$1.1B
| $2.76M | ﹤0.01% |
+31,507
| New | +$2.82M |
|
3335
Acumen Pharmaceuticals
ABOS
$179M
| $2.76M | ﹤0.01% |
+587,583
| New | +$2.21M |
|
3336
Organogenesis Holdings
ORGO
$234M
| $2.76M | ﹤0.01% |
565,802
-856,176
| -60% | -$5.27M |
|
3337
CorMedix
CRMD
$573M
| $2.76M | ﹤0.01% |
686,251
+664,473
| +3,051% | +$2.47M |
|
3338
Scilex Holding
SCLX
$47.8M
| $2.75M | ﹤0.01% |
7,670
+5,079
| +196% | +$1.81M |
|
3339
Agios Pharmaceuticals
AGIO
$1.98B
| $2.75M | ﹤0.01% |
123,830
+82,995
| +203% | +$1.87M |
|
|
CUK
3340
DELISTED
Carnival PLC
CUK
| $2.74M | ﹤0.01% |
346,671
+188,974
| +120% | +$2.55M |
|
3341
TTM Technologies
TTMI
$13.5B
| $2.73M | ﹤0.01% |
218,744
+129,200
| +144% | +$1.79M |
|
|
TGH
3342
DELISTED
Textainer Group Holdings limited
TGH
| $2.73M | ﹤0.01% |
99,667
-256,045
| -72% | -$8.27M |
|
3343
PUT
Goodyear
GT
$1.77B
| $2.73M | ﹤0.01% |
+255,000
| New | +$3.19M |
|
3344
Karyopharm Therapeutics
KPTI
$47.1M
| $2.73M | ﹤0.01% |
40,359
-43,166
| -52% | -$3.96M |
|
3345
PUT
iShares US Real Estate ETF
IYR
$4.51B
| $2.72M | ﹤0.01% |
29,600
-700,900
| -96% | -$69.9M |
|
3346
PUT
Align Technology
ALGN
$12.3B
| $2.72M | ﹤0.01% |
11,500
+9,500
| +475% | +$2.92M |
|
|
PTVE
3347
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.71M | ﹤0.01% |
272,527
+233,484
| +598% | +$2.35M |
|
|
FFIC
3348
DELISTED
Flushing Financial
FFIC
| $2.71M | ﹤0.01% |
127,269
+117,394
| +1,189% | +$2.57M |
|
3349
Medifast
MED
$132M
| $2.71M | ﹤0.01% |
14,991
+13,302
| +788% | +$2.38M |
|
3350
Navigator Holdings
NVGS
$1.23B
| $2.71M | ﹤0.01% |
239,661
+194,577
| +432% | +$2.52M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.